2012
DOI: 10.1016/j.hrthm.2011.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Acute inhibition of the Na+/Ca2+ exchanger reduces proarrhythmia in an experimental model of chronic heart failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
35
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 43 publications
(38 citation statements)
references
References 36 publications
3
35
0
Order By: Relevance
“…It is also the first study to investigate the effects of chronic and specific NCX inhibition on the generation of arrhythmia because synthetic NCX inhibitors lack specificity [19][20][21][22][23] and-to our knowledge-have only been applied acutely as single shot applications and not chronically in the investigation of arrhythmia. 23,24 …”
Section: Discussionmentioning
confidence: 99%
“…It is also the first study to investigate the effects of chronic and specific NCX inhibition on the generation of arrhythmia because synthetic NCX inhibitors lack specificity [19][20][21][22][23] and-to our knowledge-have only been applied acutely as single shot applications and not chronically in the investigation of arrhythmia. 23,24 …”
Section: Discussionmentioning
confidence: 99%
“…Prior studies have demonstrated that a relatively specific inhibitor of the NCX, SEA-0400, suppressed dofetilide-induced torsade de pointes in anesthetized dogs (35) and in Langendorffperfused rabbit hearts with drug-and hypokalemia-induced models of LQT2 and LQT3 (36), possibly by reducing [Ca 2+ ] i ( Figure 6A). The efficacy of NCX inhibitors in AF, however, is unknown.…”
Section: Ncx Inhibition Reduces Frequency Of Atrial and Ventricular Amentioning
confidence: 94%
“…SEA0400 did not decrease QTc after dofetilide administration, and failed to prevent the development of Torsades de Pointes tachyarrhythmias (TdPs) in Langendorff-perfused rabbit hearts (30,32), while in another study it effectively reduced the amplitudes of EADs, without influencing APD (56). In contrast, Milberg et al reported considerable APD shortening effect of SEA0400, furthermore, sotalol or veratridine induced TdPs were also suppressed (57,60). Recently Jost et al (10) claimed that ORM-10103, a novel NCX inhibitor with improved selectivity decreased pharmacologically induced DADs and EADs, confirming previous results performed with SEA0400 (56).…”
Section: Transmural Heterogeneity In the Ventricular Myocardiummentioning
confidence: 90%